473257-55-5

Basic information

• Product Name: Glycine, N-[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-2-yl]carbonyl]-, ethyl ester
• CAS NO: 473257-55-5
• Molecular Formula: C21H21ClN2O5S
• Molecular Weight: 448.927
• Mol File: 473257-55-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: Glycine, N-[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-2-yl]carbonyl]-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Glycine, N-[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-2-yl]carbonyl]-, ethyl ester(473257-55-5)
• EPA Substance Registry System: Glycine, N-[[5-chloro-3-[(3,5-dimethylphenyl)sulfonyl]-1H-indol-2-yl]carbonyl]-, ethyl ester(473257-55-5)

Safety Data

• Hazardous Substances Data: 473257-55-5(Hazardous Substances Data)

Upstream product

• 473258-22-9 ethyl 3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carboxylate 
• 742106-23-6 ethyl 3-[(3,5-dimethylphenyl)thio]-5-chloro-1H-indole-2-carboxylate 
• 473258-21-8 1-(3,5-dimethylphenylthio)pyrrolidine-2,5-dione 
• 4792-67-0 5-chloro-indole-2-carboxylic acid ethyl ester 

Downstream Products

• 473257-57-7 N-cyclopropyl-2-{N-[5-chloro-3-(3,5-dimethylphenylsulfonyl)-indol-2-carboxyamido]}-acetamide 
• 473257-58-8 N-(1-morpholin-4-yl)-2-{N-[5-chloro-3-(3,5-dimethylphenylsulfonyl)-indol-2-carboxyamido]}-acetamide 
• 742106-31-6 N-{3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carbonyl}glycylglycylglycine ethyl ester 
• 742106-27-0 N-{3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carbonyl}glycylglycine ethyl ester 
• 742106-29-2 N-{3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carbonyl}glycyl-D,L-alanine ethyl ester 
• 742106-30-5 N-{3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carbonyl}glycylglycine 
• 742106-25-8 N-{3-[(3,5-dimethylphenyl)sulfonyl]-5-chloro-1H-indole-2-carbonyl}glycine 

Relevant articles and documents

Simple, short peptide derivatives of a sulfonylindolecarboxamide (L-737,126) active in vitro against HIV-1 wild type and variants carrying non-nucleoside reverse transcriptase inhibitor resistance mutations

Non-nucleoside reverse transcriptase inhibitors (NNRTIs) active against NNRTI-resistant mutants were obtained by introducing two methyl groups at positions 3 and 5 of the benzenesulfonyl moiety of L-737,126 (1) and coupling one to three glycinamide/alanin